Jill BroadfootFormer CFO at aTyr PharmaSpeaker
Profile
Jill Broadfoot is a senior life science executive and public company director with more than 30 years of experience guiding emerging life science companies through critical stages of growth.
She serves on the board of Talphera, a publicly traded company developing therapies for use in medically supervised settings, where she chairs the Audit Committee. In total, Jill has served on 3 public biotech company boards including sitting on both the Audit and Nominating and Governance Committees, 1 private biotech company board and a non-profit board.
Jill is also a fractional CFO, at Twin Oaks BioPartners. A former CFO of four biotech companies, Jill is known for pairing capital markets and transactional experience with the operational discipline growth companies need to scale. Her career began in medical imaging and public accounting at EY, and has since spanned orthopedic device, biotech and cannabis-focused pharmaceutical companies. Along the way she has been involved in multiple IPOs, public and private financings, partnerships, restructurings, and M&A. Her CFO responsibilities have reached well beyond finance, including manufacturing, business development, legal, HR, IT and cybersecurity including several ERP implementations, facilities, and risk management. That breadth gives her a holistic view of the business that is valuable to boards at key inflection points, including late-stage development, launch readiness, organizational scaling and long-term value creation.
Agenda Sessions
Benchmarking the Unknown: How Finance Teams Evaluate Spend Without Industry Transparency
, 4:00pmView Session
